STEVEN K. GALSON, M.D., MPH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BIOCRYST PHARMACEUTICALS INC

Filing Date Source Excerpt
2023-04-27 Steven K. Galson, M.D., MPH, was initially appointed to the Board in September 2021... The Company’s Audit Committee currently consists of Mr. Lee, as its Chair, Mr. Abercrombie, Ms. Heggie (since February 2023), Mr. Levin, and Mr. Milano... 2022 Director Compensation: Steven K. Galson, M.D., MPH total compensation $424,848.

Data sourced from SEC filings. Last updated: 2026-02-03